Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
about
Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@en
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@nl
type
label
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@en
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@nl
prefLabel
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@en
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@nl
P2860
P356
P1433
P1476
Pharmacovigilance Assessment o ...... ibitor Cancer Immunotherapies.
@en
P2093
Ayad K Ali
David E Watson
P2860
P304
P356
10.1002/PHAR.2035
P407
P577
2017-09-26T00:00:00Z